Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS
NCT ID: NCT00267436
Last Updated: 2012-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
574 participants
INTERVENTIONAL
2006-07-31
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center
NCT00267410
Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected Men
NCT00231972
Prison Connect-STI/HIV Prevention Intervention for Couples Affected by Incarceration
NCT03025191
Positive Lifestyles Using Safety
NCT00836290
Type 1 Hybrid Trial of Our Plan - a Brief, Couples-based HIV/STI Prevention Intervention
NCT05193942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the first two months of the ADAPT project, the Boston and MSP sites will conduct formative evaluation activities (i.e., a comprehensive literature review, focus groups, and individual interviews) to assess the needs of the target population and organizational capacities to serve them. Results will be used to inform the adaptation of the original intervention to ensure that CP PLUS meet the expressed needs of the target population.
Process data will also be collected from various sources throughout the life of the project. Process data will be collected through staff meetings, interviews with staff, focus groups with peer advocates, and an expert panel consultation. Process data will be extremely useful for ensuring program objectives are met, improving CP PLUS, and providing information for providers in other locales who may be interested in adapting this intervention to serve this target population.
The Boston and MSP sites will also conduct outcome monitoring through collection of data concerning risk behaviors pre- and post-intervention implementation (follow-up at 6-8 months post and 11-13 months post \[Boston only\]) to determine if the adapted intervention has met its outcome objectives. Outcome monitoring will also be conducted for the "parent" intervention at both sites for HIV- or unknown status men who have sex with men.
In addition to the project activities, the organization will be examining the utility of the CDC draft guidance. The Boston and MSP sites are two of five case studies throughout the United States that will detail the challenges, successes and lessons learned from adapting an intervention packaged by CDC's Replicating Effective Programs (REP) and disseminated by Diffusing Effective Behavioral Interventions (DEBI) to a specific population. These findings will help other community-based organizations and Health Departments effectively adapt and tailor group, individual and community-level interventions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Community PROMISE
The Community PROMISE begins with a community assessment to identify HIV risk factors. Once risk factors have been identified, individuals from the targeted at-risk community are recruited and trained to be peer advocates. Trained peer advocates interview members of the community about their behavior. Role model stories are written based on the interviews. Role model stories are personal accounts from individuals in the target population which explain how and why they took steps to practice HIV risk-reduction behaviors and the positive effects the choice has had on their lives. Each week, peer advocates distribute role model stories and supplies, such as condoms, to 10 to 20 members of their social networks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-reports as HIV+ (for CP PLUS cohort)
* Self-report that they had sex with men in the past 3 years (MSP) or 1 year (Boston)
* Self-reports as a resident of the identified geographic areas.
* Identifies as African American
* 18 years of age, or older.
HIV- cohort
* HIV- or unknown status only, has engaged in risky sexual contact (defined as those who self-report engaging in unprotected anal or vaginal intercourse within the past year)
* Self-report that they had sex with men in the past 3 years (MSP) or 1 year (Boston)
* Identifies as African American (MSP); No racial/ethnic criteria however AA will be over-sampled and will be at least 20% of sample
* 18 years of age, or older.
* Self-reports as a resident of the identified geographic areas.
* Engage in risky sex (defined as individuals who self-report engaging in unprotected anal or vaginal intercourse within the past year.
Exclusion Criteria
* Under 18 years of age
* Plans to relocate within 12 months after baseline interview
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minneapolis Urban League;
UNKNOWN
University of Minnesota
OTHER
AIDS Action Committee of Massachusetts
OTHER
The Fenway Institute
OTHER
Centers for Disease Control and Prevention
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Centers for Disease Control and Prevention
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer S Galbraith
Role: STUDY_DIRECTOR
Centers for Disease Control and Prevention
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AIDS Action Committee
Boston, Massachusetts, United States
Minneapolis Urban League
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U65/CCU523908-01
Identifier Type: -
Identifier Source: secondary_id
CDC-NCHSTP-U65/CCU523908
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.